Psychedelics are a class of drugs that produce unique subjective effects via agonist actions at the 5-hydroxytryptamine 2A receptor (5-HT 2A ). The 5-HT 2A -mediated head twitch response (HTR) in rodents is used as a reliable proxy for psychedelic drug activity in humans, but existing methods for measuring HTRs require surgery or time-consuming visual scoring. In the present work, we validated a simple noninvasive method for quantitating HTRs using computer-based analysis of experimental video recordings. Male C57BL/6J mice received injections of the 5-HT 2 receptor agonist (±)2,5-dimethoxy-4-iodoamphetamine (DOI; 0.03−3 mg/kg, s.c.) and were placed into cylindrical arenas. High frame rate videos were recorded via cameras mounted above the arenas. Antagonist experiments, which entailed pretreatment with the 5-HT 2A antagonist M100907 (0.01 or 0.1 mg/kg s.c.) prior to DOI (1 mg/kg s.c.), were also recorded. The experimental videos were analyzed for HTRs using a newly developed feature of a commercial software package and compared to visual scoring carried out by trained observers. As expected, DOI produced dose-related increases in HTRs, which were blocked by M100907. Computer scoring was positively correlated with visual scoring, and no statistical difference between the two methods was found. The software captured nearly all visually observed HTRs, false positives induced by other behaviors (e.g., grooming) were rare and easily identified, and results were improved by optimizing lighting conditions. Our findings demonstrate the utility of combining high frame rate video recordings with commercial software analyses to measure HTRs, validating an additional reliable method to study psychedelic-like drug activity in mice.
HYPOTHESIS Phenethylamine analogs are often found in dietary supplements, even though they are rarely listed on the ingredient label. Due to their structural similarities to amphetamine, it is anticipated that these compounds display comparable pharmacological effects to amphetamine and other stimulants. Here, we compared the effects of amphetamine and selected phenethylamine analogs on drug self‐administration behavior in rats. METHODS Male Sprague‐Dawley rats fitted with intravenous (i.v.) jugular catheters were placed in experimental chambers containing two nose poke holes. Active nose poke responses resulted in delivery of a constant volume of drug (0.2 mL) over a period of 2 s on a fixed‐ratio 1 schedule, followed by a 20 s timeout. Acquisition doses for the compounds were 0.1 mg/kg/inj amphetamine, 1 mg/kg/inj a‐ethylphenethylamine (AEPEA) and N,a‐diethylphenethylamine (DEPEA), and 3 mg/kg/inj b‐methylphenethylamine (BMPEA). Following 10 days of acquisition training, dose‐effect testing began with three additional doses, each of which were tested for 3 days. Subjects then returned to the original training dose until responses stabilized. RESULTS At the end of acquisition training, all four compounds showed a significant difference in active versus inactive nose pokes (p<0.0001), indicating that subjects acquired drug self‐administration. During dose‐effect testing, all the drugs showed a typical inverted dose‐effect function, although there were clear differences in potency. Maximum responding was maintained at 0.03 mg/kg/inj for amphetamine, 0.3 mg/kg/inj for DEPEA and AEPEA and over 1 mg/kg/inj for BMPEA. AEPEA and DEPEA appeared to maintain higher rates of responding than amphetamine, potentially reflecting differences in duration of action. Self‐administration of BMPEA occurred despite BMPEA showing minimal locomotor stimulating effects in a previous experiment. CONCLUSION Direct comparisons between the three phenethylamine analogs and amphetamine show that these compounds support self‐administration, indicating that dietary supplements containing these compounds could have significant abuse liability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.